Pinnacle Medicines closes an oversubscribed $89 million Series B financing led by LAV and Foresite Capital to advance its oral peptide therapeutics in clinical trials.
Amount Raised
$89 Million
Round Type
Series B
Investors
Description
Pinnacle Medicines has announced the closing of $89 million Series B financing, co-led by LAV and Foresite Capital. Proceeds will support the advancement of its lead programs through clinical proof of concept in immunology and cardiometabolic diseases. The company aims to further expand its peptide discovery platform and R&D capabilities. This financing reflects strong conviction in the potential of oral peptide therapeutics.
Quick answer
Pinnacle Medicines raised $89 Million in a Series B round, dated March 26, 2026. Investors: Orbimed, Logos Capital, Quan Capital, Hankang Capital, RA Capital Management, Lav and Foresite Capital.
- How much did Pinnacle Medicines raise?
- Pinnacle Medicines raised $89 Million in a Series B round on March 26, 2026.
- Who invested in Pinnacle Medicines?
- Orbimed, Logos Capital, Quan Capital, Hankang Capital, RA Capital Management, Lav and Foresite Capital are named as investors in this round.
- What does Pinnacle Medicines do?
- Pinnacle Medicines is a biotechnology company focused on developing a new generation of oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Pinnacle Medicines that raised within 45 days of this round, from Fundz verified event records.
- Citius Oncology raised $37M on May 6, 2026.
- Remedium Bio raised $10M (Series A) on May 6, 2026.
- Windward Bio raised $165M (Funding Round) on May 5, 2026.
- Aura Biosciences, Inc. raised $238M (Post-IPO Equity) on May 4, 2026.
- Cue Biopharma raised $30M on May 4, 2026.
- mbiomics raised $35M (Series A) on April 29, 2026.
Who to call at Pinnacle Medicines, and when
A new round usually means Pinnacle Medicines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pinnacle Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pinnacle Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pinnacle Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pinnacle Medicines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansPinnacle Medicines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.